These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1130974)
61. [Synthetic studies using 2-(1-cyclohexenyl)cyclohexanone as the starting material (author's transl)]. Terada Y; Okada J Yakugaku Zasshi; 1977 Feb; 97(2):207-10. PubMed ID: 558323 [No Abstract] [Full Text] [Related]
62. [The effect of sex hormones on hexobarbital activity in rat; duration of hexobarbital retention in rat]. BUCHEL L Anesth Anal; 1954 Jun; 11(2):268-79. PubMed ID: 15444604 [No Abstract] [Full Text] [Related]
63. [Action of barbituric acid derivatives on the physiocochemical properties of DNA]. Kudrin VS; Osniach VS; Matiushin AI Farmakol Toksikol; 1978; 41(3):314-6. PubMed ID: 658378 [TBL] [Abstract][Full Text] [Related]
64. Metabolism of drugs. XXXI. Metabolic fate of methylhexabital (5-cyclohexenyl-3,5-dimethylbarbituric acid). 10. Enzymatic oxidation of methylhexabital. TOKI S; TOKI K; TSUKAMOTO H Chem Pharm Bull (Tokyo); 1962 Aug; 10():708-14. PubMed ID: 13985309 [No Abstract] [Full Text] [Related]
65. [Metabolism of 5-(4-oxo-delta3-cyclohexenyl)-5-allylbarbituric acid in rabbits (author's transl)]. Nakashima K Yakugaku Zasshi; 1978 Jan; 98(1):133-6. PubMed ID: 641696 [No Abstract] [Full Text] [Related]
66. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation. Aki H; Niiya T; Iwase Y; Yamamoto M J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223 [TBL] [Abstract][Full Text] [Related]
67. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig. van den Broek JM; Teunissen MW; Breimer DD Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813 [TBL] [Abstract][Full Text] [Related]
68. Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates. Nims RW; Devor DE; Henneman JR; Lubet RA Carcinogenesis; 1987 Jan; 8(1):67-71. PubMed ID: 3492311 [TBL] [Abstract][Full Text] [Related]
69. Potential coenzyme inhibitors. V. The synthesis and some properties of 4-methylnicotinamide adenine dinucleotide. Jarman M; Searle F Biochem Pharmacol; 1972 Feb; 21(4):455-64. PubMed ID: 4335405 [No Abstract] [Full Text] [Related]
70. Effect of nephrectomy on the duration of sleep following administration of thiopental and hexobarbital. RICHARDS RK; TAYLOR JD; KUETER KE J Pharmacol Exp Ther; 1953 Aug; 108(4):461-73. PubMed ID: 13070167 [No Abstract] [Full Text] [Related]
71. [Synthesis of barbituric acid]. Wojciechowski J; Rudnicki A; Mleczko T Acta Pol Pharm; 1973; 30(3):345-6. PubMed ID: 4726065 [No Abstract] [Full Text] [Related]
72. Rapid differentiation of barbiturates in blood serum by thin-layer chromatography. LEHMANN J; KARAMUSTAFAOGLU V Scand J Clin Lab Invest; 1962; 14():554-8. PubMed ID: 13929359 [No Abstract] [Full Text] [Related]
73. [SEPARATION OF SOME BARBITURATES WITH THIN LAYER CHROMATOGRAPHY AND THE EFFECT OF ADSORBENT BUFFERING]. PORGES E Bratisl Lek Listy; 1964; 44():3-7. PubMed ID: 14139399 [No Abstract] [Full Text] [Related]
75. Reductive ring openings of glutarimides and barbiturates with sodium borohydride. Kondo Y; Witkop B J Org Chem; 1968 Jan; 33(1):206-12. PubMed ID: 5634894 [No Abstract] [Full Text] [Related]
76. [Nicotinic acid derivatives. 3. Synthesis of 2,5-dihydroxynicotinic acid]. Nantka-Namirski P; Rykowskki A Acta Pol Pharm; 1972; 29(2):125-9. PubMed ID: 5077362 [No Abstract] [Full Text] [Related]
77. [Induction of anesthesia in pediatric surgery, with special reference to the hexobarbital sodium preparation Heyden]. STRAHL U Zentralbl Chir; 1956; 81(2):71-7. PubMed ID: 13312563 [No Abstract] [Full Text] [Related]
78. [Synthesis of 1,4-benzodiazepine and 1,5-benzodiazocine through oxidative fission of the double bond of indole derivatives]. Gatta F; Chiavarelli S Farmaco Sci; 1977 Jan; 32(1):33-9. PubMed ID: 844603 [TBL] [Abstract][Full Text] [Related]
79. Impairment of hepatic drug metabolism in calcium deficiency. Dingell JV; Joiner PD; Hurwitz L Biochem Pharmacol; 1966 Jul; 15(7):971-6. PubMed ID: 5967908 [No Abstract] [Full Text] [Related]
80. Interference of barbiturates with pyrimidine incorporation. II. Structural specificity of the inhibition of orotate uptake in Bacillus cereus. Mandel HG; Riis M Biochem Pharmacol; 1970 Jun; 19(6):1867-77. PubMed ID: 4398023 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]